Intratumoural expression of anti-tumoural chemokines such as CXCL9, CXCL10 and CCL5 were reported in patients undergoing chemotherapy for multiple cancer types such as melanoma, non-small cell lung cancer (NSCLC) and BC (20). This evidence concerns the gene CXCL9 and melanoma.